
The funding will be for a GLP-1 receptor agonist clinical programme for weight loss

Genesis Research Group today announced the appointment of Sarah Alwardt, PhD, as Executive Vice President, RWE/HEOR. She joins the Executive Leadership Team and will lead the company’s global real-world evidence...

Cladribine capsules could become the first ever oral treatment for gMG

The new facility in Texas is expected to create 4,615 manufacturing and construction jobs

The company will create 2,450 high-wage manufacturing and construction jobs

Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Uniphar to manage the distribution of AGAMREE® (vamorolone) in the United Arab Emirates, the Kingdom of Saudi Arabia,...

HealthEconomics.com interviews David W. Miller, CEO of Genesis Research Group, to discuss the unique challenges faced by biotech companies in evidence generation, market access, and stakeholder engagement.

SpringWorks’ Gomekli was approved by the FDA earlier this year to treat patients with NF1

The Medscape Education Global team is excited to announce its participation in Swiss Biotech Day, taking place in Basel from May 5-6. This marks our inaugural attendance at this event,...

The neurological disorder affects more than 150,000 people in the UK

The companies entered into a licensing agreement for the candidate in December last year

The deal aims to advance Merck’s viral vector manufacturing of cell and gene therapies